Roshan Koul1, Bikrant Bihari Lal2, Viniyendra Pamecha3, Shiv Sarin2, Seema Alam2. 1. Pediatric Neurology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India. 2. Pediatric Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India. 3. Hepatobiliary Surgery, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India.
Abstract
OBJECTIVES: To report 2 children with acute hepatic myelopathy after hepatitis A infection who recovered completely after living donor liver transplantation. METHODS: All the children admitted into liver intensive care unit (LICU) from November 1st 2018 to 31st October 2019, were evaluated for the neurological features. The data was collected from the admission register of the LICU unit in children below 15 years age. Medical records of these children were reviewed and data collected. Established clinical criteria were used to categorize the various grades of hepatic encephalopathy/myelopathy. RESULTS: 37 children were seen over 1-year period between 6 months to 15 years age. There were 24 male(64.9%) and 13 females. Acute liver failure was seen in 19 (51.3%) and acute on chronic liver failure in 18 (48.7%). There were 10 cases of hepatitis A in acute liver failure group,10 of 19 cases (52.6%), while Wilson's disease and undetermined etiology group formed the chronic group. 2 cases of hepatic myelopathy were seen in acute liver failure following hepatitis A infection. Both these children underwent live liver donor transplantation and recovered completely. Further in hepatitis A group,3 children had spontaneous recovery, 4 died and 1 child was discharged with end of life care. Overall out of all 37 children with liver failure,20 (54%) were discharged, 6 (16.2%) were advised end of life care and 11 (29.8%) died. CONCLUSION: Two cases (10.5%) of reversible hepatic myelopathy were seen in acute liver failure group of 19 cases. 18 out of 37 (48.6%) children had residual neurological features at discharge time.
OBJECTIVES: To report 2 children with acute hepatic myelopathy after hepatitis A infection who recovered completely after living donor liver transplantation. METHODS: All the children admitted into liver intensive care unit (LICU) from November 1st 2018 to 31st October 2019, were evaluated for the neurological features. The data was collected from the admission register of the LICU unit in children below 15 years age. Medical records of these children were reviewed and data collected. Established clinical criteria were used to categorize the various grades of hepatic encephalopathy/myelopathy. RESULTS: 37 children were seen over 1-year period between 6 months to 15 years age. There were 24 male(64.9%) and 13 females. Acute liver failure was seen in 19 (51.3%) and acute on chronic liver failure in 18 (48.7%). There were 10 cases of hepatitis A in acute liver failure group,10 of 19 cases (52.6%), while Wilson's disease and undetermined etiology group formed the chronic group. 2 cases of hepatic myelopathy were seen in acute liver failure following hepatitis A infection. Both these children underwent live liver donor transplantation and recovered completely. Further in hepatitis A group,3 children had spontaneous recovery, 4 died and 1 child was discharged with end of life care. Overall out of all 37 children with liver failure,20 (54%) were discharged, 6 (16.2%) were advised end of life care and 11 (29.8%) died. CONCLUSION: Two cases (10.5%) of reversible hepatic myelopathy were seen in acute liver failure group of 19 cases. 18 out of 37 (48.6%) children had residual neurological features at discharge time.
Neurological complications are often seen with chronic liver disease.[1,2] Extrapyramidal features and neuropsychiatric manifestations are common in
chronic liver diseases.[2] Hepatic encephalopathy (HE), the most serious and life threatening condition
is seen in acute liver failure and in acute on chronic liver disease.[2] Raised intracranial pressure, a life threatening condition seen in acute HE,
is not a common feature in the chronic liver disease.[3] Spinal cord involvement is an uncommon complication and is usually associated
with extensive porto-systemic shunt of blood either surgically created or occurring
spontaneously in chronic liver disease.[2,4] Spinal cord involvement is labeled as hepatic myelopathy. Hepatic myelopathy
is more often a feature of chronic liver disease but can be seen in acute hepatic encephalopathy.[4,5] Hepatic myelopathy following acute fulminant liver failure is rarely seen and
reported. Two children in our series had hepatic myelopathy following HE after acute
fulminant hepatitis A infection, which reversed after liver transplantation
(LT).
Methods
All the children admitted into liver intensive care unit (LICU) from November 1st
2018 to 31st October 2019, were evaluated for the neurological outcome. The data was
collected from the admission register of the LICU unit in all children below 15
years age. All the medical records of these children were seen and data collected.
The diagnosis of HE was based on well-established clinical criteria in children and
was graded into 4 grades.[6] The indication for admission to LICU was presence of grade 3 or 4 HE
requiring ventilator support or plasma exchange. An initial neurological examination
was made before admission to LICU. Neurological assessment was also done after
transfer from LICU to the ward. Final neurological examination and outcome were
assessed at the time of discharge. King’s College Hospital criteria was used to list
the children for liver transplantation [LT] and LT was done based on trend of rising
international normalized ratio (INR) and increasing HE.[7] The institute has a living donor LT program. Plasmapheresis was done as a
bridge to LT whenever there was a delay.[8] The children requiring liver transplant were assessed before, after liver
transplantation and at discharge. The children undergoing plasmapheresis were
assessed in the ward at the time of discharge from hospital. Baseline blood
including complete blood count, liver biochemical tests, PT, APTT, serum copper,
serum ceruloplasmin, autoimmune profile, ammonia, renal functions, hepatitis profile
and day to day blood tests were done. Imaging of the abdomen was done in all. Brain
imaging and EEG were done when the clinical condition required. The children with
myelopathy were diagnosed after liver transplantation (LT) when there was complete
reversal of encephalopathy but there was weakness of upper and lower limbs with
sphincteric involvement. Myelopathy was diagnosed on the classic features of upper
motor neuron signs in upper and lower limbs. MRI brain and spine were done in both
children to rule out other causes in brain and spine. Nerve conduction study was
also done in them.
Case Summaries
Case 1
A 5 year 8 months boy presented in a critical condition to the hospital
emergency of institute of liver and biliary sciences (ILBS). The boy had 3
days history of jaundice, 1 day history of deranged sensorium. He was
intubated before transfer from a peripheral hospital. At admission he had
bradycardia (heart rate of 45/minute) and pupils were reacting both sides.
Laboratory work up revealed INR 3.17, serum bilirubin of 25.3mg/dl
(15.6mg/dl direct), ASAT-1035 (5-40 IU/L), ALAT-1358 (10-40 IU/L), serum
ammonia ranged between 290-434 (12-60 ug/L), normal ceruloplasmin 0.21
(0.2-0.6 g/L).HIV profile was negative. ANA, double stranded DNA were
negative. Hepatitis B, C and E were negative. IgM Hepatitis A antibody was
positive. Renal functions were normal. EEG revealed bi-hemispherical delta
activity suggestive of encephalopathy with raised intracranial pressure. An
urgent living donor LT was performed within 72 hours of hospitalization with
father as donor. The surgery was uneventful without any complications. The
child was extubated 24 hours after LT. After 48 hours of liver
transplantation encephalopathy started improving but he was not able to move
upper and lower limbs. Examination revealed normal cranial nerves. Both
upper and lower limbs had grade 1/5 power. Deep tendon reflexes were
exaggerated and plantars were upgoing. MRI brain and spinal cord were
normal. Nerve conduction study was normal. Liver functions returned to
normal in 2 months time. His power in limbs improved gradually. He was able
to sit after 2 weeks, stand after 4 weeks and walking at the day of
discharge (60 day of hospitalization).
Case 2
A 5 year girl presented to the emergency of ILBS hospital with hepatic
encephalopathy and raised intracranial pressure. She had been intubated
outside due to grade 4 HE. On examination the pupils were reacting both
sides. Laboratory work up revealed INR 5.6, serum bilirubin of 23.6mg/dl
(10mg/dl direct), ASAT-1174 (5-40 IU/L), ALAT-336 (10-40 IU/L), serum
ammonia ranged between 334-443 (12-60 ug/L), normal ceruloplasmin 0.22
(0.2-0.6 g/L).HIV profile was negative. ANA, double stranded DNA were
negative. Hepatitis B, C and E were negative. IgM anti HAV was reactive.
Hepatitis A antigen was positive. Renal functions were normal. CT brain was
normal. EEG revealed bilateral delta activity. She underwent living donor LT
within 36 hours of admission with mother as donor. She required prolonged
ventilation and underwent tracheostomy on post operative day 13. While
recovering from encephalopathy weakness of upper and lower limbs was noted.
She had features of upper motor neuron lesion in both upper and lower limbs.
MRI brain and spinal cord was normal. Nerve conduction was normal.The girl
recovered gradually and was able to walk after 2 months of liver
transplantation.
Results
37 children were admitted in LICU over 1 year period. The age ranged between 6 months
to 15 years of age with a mean of 8.9 years. There were 24 male (64.9%) and 13
females (35.1%). Acute liver failure (ALF) was seen in 19 (51.3%) and acute on
chronic liver failure in 18 (48.7%). Hepatitis A was the main cause in ALF group 10
out of 19 (52.6%), Wilson disease and undetermined cause in chronic group.
Associated multi-organ involvement was seen in 4, renal failure in 3 and pneumonia
in 1. Table 1 shows
types of liver disease and neurological work up. Neurological features and outcome
are given in the Table
2. Two children with acute hepatic myelopathy were seen after recovering from
hepatic encephalopathy. They recovered completely in about 8 and half weeks(60 days)
after LT.
Table 1.
Shows Types of Liver Disease and Neurological Work up.
Features
Conditions
Number
Types of liver disease
Hepatitis A
10
27.0 %
Hepatitis E
1
2.7 %
Autoimmune hepatitis
3
8.1 %
Biliary atresia (BA)
8
21.6 %
Wilson
7
18.9 %
Undetermined
7
18.9 %
Drug induced
1
2.7 %
HE grades clinical
1
5
13.5 %
2
9
24.3 %
3
8
21.6 %
4
15
40.5 %
Procedures
Liver transplant
11(Hepatitis A-2,Biliary
atresia-5,Unknown-4)
Plasma exchange
13
EEG (6)
Grade 4
5
Normal
1
Brain imaging (7)
MRI-
4
Basal ganglia changes
1
Hemorrhage
1
Normal
2
CT-
3
Edema
1
Normal
2
Percentage of 4, 5, 6 rows not done as the number is small.
Shows Types of Liver Disease and Neurological Work up.Percentage of 4, 5, 6 rows not done as the number is small.Shows Neurological Features and Outcome.
Discussion
Neurological complications are often seen with chronic liver disease.[1,2] Extrapyramidal features and neuropsychiatric features are common in chronic
liver diseases.[2] Hepatic encephalopathy is the most serious and life threatening condition
seen in acute liver failure and in acute on chronic liver disease.[2] Raised intracranial pressure is the life threatening condition seen in acute
hepatic encephalopathy,[3] which is not a common feature in the chronic liver disease. Intracranial
hemorrhages, focal deficit and seizures are uncommon but seen in these children.[2] Spinal cord involvement is uncommon and usually associated with extensive
porto-systemic shunt of blood either surgically created or occurring spontaneously
in chronic liver disease.[4,5] Spinal cord involvement is labeled as Hepatic myelopathy (HM).It is most
often seen in chronic liver disease.[9-11] Acute hepatic myelopathy gets obscured by dominant encephalopathy in acute
liver failure, hence less often reported. The underlying mechanism for hepatic
myelopathy on autopsy studies have shown selective demyelination of corticospinal
tracts, possible due to the nitrogenous toxins like ammonia.[10] There is symmetrical loss of myelin in the lateral pyramidal tracts, with
demyelination beginning in the cervical spine, becoming more intense at lower
levels, and occasionally being associated with axonal loss.[5,10] In the early stages, demyelination seems to predominate, but as the disease
progresses, axonal loss occurs, and this is likely to be irreversible.[10] MRI studies have shown abnormalities in the corticospinal tracts but often
there are no abnormalities seen in the spinal cord.[5] In a detailed review from 1966 to 2013, 90 cases of HM were diagnosed. The
first description of the case of the HM goes to 1949.[5,10]Hepatic myelopathy is difficult to diagnose in acute liver failure encephalopathy as
acute encephalopathy obscures the signs of myelopathy and particularly when the
patient is in higher grades of encephalopathy or intubated. After the liver
transplant these patients recover rapidly in higher functions but they are unable to
move upper and lower limbs. Examination reveals typical upper motor neuron features
in the limbs characteristic of myelopathy. A pathology anywhere in the corticocpinal
tracts could manifest as weakness of upper and lower limbs. Normal higher mental
functions, language and cranial nerves after extubation suggest pathology in the
spinal cord most likely when there is acute weakness of upper and lower limbs.This
pattern was seen in our 2 cases. A normal MRI has been reported in patients with
myelopathy due to cirrhosis.[5] One has to differentiate hepatic myelopathy from compressive and
non-compressive myelopathy, transverse myelitis,[12] acute myo-neuropathy associated with hepatitis A infection[13] and critical care / intensive care associated neuropathy in these patients.
In this latter condition, the weakness is of lower motor neuron type with areflexia.
Nerve conduction study further helps in differentiating this from myelopathy. MRI is
often normal in hepatic myelopathy, as it was in both of our children.[5] Medical treatment and shunt surgeries have made some improvement in
myelopathy but liver transplantation may reverse the neurological deficit.[10,14] The grade of improvement is related to the time interval between onset of the
first symptoms of hepatic myelopathy and liver transplantation.[5,10] If the liver transplant is done early there is complete reversal of the
myelopathy. Recovery of myelopathy after liver transplantation is slow and may be
incomplete in chronic liver disease as these patients have undergone axonal loss due
to the chronicity of the disease. However in acute liver failure associated
myelopathy, the recovery is fast and complete as these patients have only
demyelinating changes and not the axonal loss.[5,14] Furthermore these patients receive steroids and tacrolimus after liver
transplantation which may also be helpful in recovery. After liver transplantation
our 2 children had a rapid recovery on follow up.
Conclusions
Acute reversible hepatic myelopathy is uncommon and rarely reported. It becomes
obvious after recovery from hepatic encephalopathy when the person is not able to
move the limbs. Rapid recovery suggests demyelinating mechanism involved in the
spinal cord. This weakness has to be differentiated from other causes in brain,
spine, nerves and muscles.
Authors: Robert H Squires; Benjamin L Shneider; John Bucuvalas; Estella Alonso; Ronald J Sokol; Michael R Narkewicz; Anil Dhawan; Philip Rosenthal; Norberto Rodriguez-Baez; Karen F Murray; Simon Horslen; Martin G Martin; M James Lopez; Humberto Soriano; Brendan M McGuire; Maureen M Jonas; Nada Yazigi; Ross W Shepherd; Kathleen Schwarz; Steven Lobritto; Daniel W Thomas; Joel E Lavine; Saul Karpen; Vicky Ng; Deirdre Kelly; Nancy Simonds; Linda S Hynan Journal: J Pediatr Date: 2006-05 Impact factor: 4.406
Authors: Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei Journal: Hepatology Date: 2002-03 Impact factor: 17.425
Authors: Karin Weissenborn; Uwe J F Tietge; Martin Bokemeyer; Bahram Mohammadi; Ulriue Bode; Michael P Manns; Martin Caselitz Journal: Gastroenterology Date: 2003-02 Impact factor: 22.682